Michael Esquerre

Michael Esquerre is a notable inventor based in Auzielle, France. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric proteins. With a total of 2 patents, his work focuses on innovative solutions for inducing immune responses.

Latest Patents

Esquerre's latest patents include groundbreaking inventions related to CyaA-based chimeric proteins. These proteins consist of a N-terminal part of a CyaA protein, a heterologous polypeptide, and a C-terminal part of a CyaA protein. The inventions also encompass polynucleotides encoding a deleted version of CyaA, as well as those encoding the chimeric protein itself. Furthermore, the patents detail compositions comprising these chimeric proteins and their prophylactic and therapeutic uses.

Career Highlights

Throughout his career, Michael Esquerre has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Genticel and Genkyotex, where he has contributed to various innovative projects. His expertise in chimeric protein technology has positioned him as a key figure in the industry.

Collaborations

Esquerre has collaborated with several professionals in his field, including Yolande Misseri and Etienne Joly. These collaborations have further enhanced his research and development efforts in biotechnology.

Conclusion

Michael Esquerre's contributions to the field of chimeric proteins and immune response induction are noteworthy. His innovative patents and collaborations reflect his commitment to advancing biotechnology. His work continues to influence the industry and pave the way for future innovations.

Profile summary based on public USPTO records.